TRVI - Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02
2023-08-10 17:48:49 ET
- Trevi Therapeutics press release ( NASDAQ: TRVI ): Q2 GAAP EPS of -$0.07 beats by $0.02 .
- The Company ended the second quarter of 2023 with $94.2 million in cash, cash equivalents and marketable securities.
For further details see:
Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02